{"schema_version":"secwatch.filing_event.v1","accession":"0001127537-24-000013","form_type":"8-K","ticker":"LUNG","cik":"0001127537","company_name":"Pulmonx Corp","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.470005+00:00","generated_at":"2026-06-05T21:42:19.785264+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pulmonx Q4 revenue $19.3M (+25% YoY); full-year 2023 revenue $68.7M (+28% YoY)","bullets":["Record Q4 U.S. revenue of $13.7M (+45% YoY); added 14 new Zephyr Valve treatment centers.","Gross margin improved to 75% in Q4; full-year gross margin flat at 74%.","Net loss of $13.9M ($0.36/share) in Q4; full-year net loss $60.8M ($1.60/share).","Adjusted EBITDA loss narrowed to $39.0M in 2023 from $41.1M in 2022.","2024 revenue guidance of $81-84M; expects gross margin 74-75% and OpEx $132-134M."],"urls":{"canonical":"https://secwatch.observer/filing/0001127537-24-000013","json":"https://secwatch.observer/filing/0001127537-24-000013.json","markdown":"https://secwatch.observer/filing/0001127537-24-000013.md","text":"https://secwatch.observer/filing/0001127537-24-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000013/0001127537-24-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000013/lung-20240221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T21:42:19.785264+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f475808007f1bb73a5698188e341af1fa6bb855","claim":"Pulmonx Corp reported fourth quarter ended December 31, 2023 results: revenue $19.3 million, net income $13.9 million net loss, EPS -$0.36 per share.","evidence_excerpt":"Total worldwide revenue in the fourth quarter of 2023 was $19.3 million, a 25% increase from $15.4 million in the fourth quarter of 2022 and an increase of 23% on a constant currency basis.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000013/0001127537-24-000013-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$19.3 million"},{"label":"Net income","value":"$13.9 million net loss"},{"label":"EPS","value":"-$0.36 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"45a274820a1f32371cb9e97833b2a27681f48db3","claim":"Pulmonx Corp reported full year 2024 results: revenue $81 million to $84 million. Guidance initiated.","evidence_excerpt":"Pulmonx expects revenue for the full year 2024 to be in the range of $81 million to $84 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000013/0001127537-24-000013-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2024"},{"label":"Revenue","value":"$81 million to $84 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"74361ad0e38eabe6c1646a9c5a623b8174e6990f","claim":"Pulmonx Corp reported full year ended December 31, 2023 results: revenue $68.7 million, net income $60.8 million net loss, EPS -$1.60 per share.","evidence_excerpt":"Total worldwide revenue for the full year of 2023 was $68.7 million, a 28% increase from $53.7 million for the full year of 2022 and an increase of 28% on a constant currency basis.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753724000013/0001127537-24-000013-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year ended December 31, 2023"},{"label":"Revenue","value":"$68.7 million"},{"label":"Net income","value":"$60.8 million net loss"},{"label":"EPS","value":"-$1.60 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}